CLINICAL_TRIALS
trial_result
· 2017-07-12
Clinical Trial Update: Phase III Study of ISU302 in Patients With Type 1 Gaucher Disease [Phase 3]
Summary
A Phase 3 trial evaluating ISU302 in Type 1 Gaucher disease has completed enrollment and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ISU Abxis Co., Ltd. | Conditions: Gaucher Disease, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2017-07-12